Literature DB >> 12659851

Mutations in protein kinase subdomain X differentially affect MEKK2 and MEKK1 activity.

Jianhe Huang1, Zheng Tu, Frank S Lee.   

Abstract

MAPK/ERK kinase kinase 2 (MEKK2) is a member of the mitogen-activated protein kinase kinase kinase (MAP3K) family of protein kinases. MAP3Ks are components of a three-tiered protein kinase pathway in which a MAP3K phosphorylates and activates a mitogen-activated protein kinase kinase (MAP2K), which in turn activates a mitogen-activated protein kinase (MAPK). We have previously identified residues within protein kinase subdomain X in the MAP3K, MEKK1, that are critical for its interaction with the MAP2K, MKK4, and MEKK1-induced MKK4 activation. We report here that kinase subdomain X also plays a critical role in MEKK2 activity. Select point mutations in subdomain X impair MEKK2 phosphorylation of the MAP2Ks, MKK7 and MEK5, abolish MEKK2-induced activation of the MAPKs, JNK1 and ERK5, and diminish MEKK2-dependent activation of an AP-1 reporter gene. Interestingly, the spectrum of mutations in subdomain X of MEKK2 that affects its activity is overlapping with but not identical to those that have effects on MEKK1. Thus, mutations in subdomain X differentially affect MEKK2 and MEKK1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12659851     DOI: 10.1016/s0006-291x(03)00387-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Autoactivation of transforming growth factor beta-activated kinase 1 is a sequential bimolecular process.

Authors:  Roland Scholz; Corinne L Sidler; Ramon F Thali; Nicolas Winssinger; Peter C F Cheung; Dietbert Neumann
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

2.  Homo-oligomerization and activation of AMP-activated protein kinase are mediated by the kinase domain alphaG-helix.

Authors:  Roland Scholz; Marianne Suter; Théodore Weimann; Cécile Polge; Petr V Konarev; Ramon F Thali; Roland D Tuerk; Benoit Viollet; Theo Wallimann; Uwe Schlattner; Dietbert Neumann
Journal:  J Biol Chem       Date:  2009-08-03       Impact factor: 5.157

3.  Conservation, variability and the modeling of active protein kinases.

Authors:  James D R Knight; Bin Qian; David Baker; Rashmi Kothary
Journal:  PLoS One       Date:  2007-10-03       Impact factor: 3.240

4.  Biochemical and pathological changes result from mutated Caveolin-3 in muscle.

Authors:  José Andrés González Coraspe; Joachim Weis; Mary E Anderson; Ute Münchberg; Kristina Lorenz; Stephan Buchkremer; Stephanie Carr; René Peiman Zahedi; Eva Brauers; Hannah Michels; Yoshihide Sunada; Hanns Lochmüller; Kevin P Campbell; Erik Freier; Denisa Hathazi; Andreas Roos
Journal:  Skelet Muscle       Date:  2018-08-28       Impact factor: 4.912

5.  miR-302a inhibits human HepG2 and SMMC-7721 cells proliferation and promotes apoptosis by targeting MAP3K2 and PBX3.

Authors:  Meng Wang; Guoyue Lv; Chao Jiang; Shuli Xie; Guangyi Wang
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

Review 6.  MKK7, the essential regulator of JNK signaling involved in cancer cell survival: a newly emerging anticancer therapeutic target.

Authors:  Jae Gwang Park; Nur Aziz; Jae Youl Cho
Journal:  Ther Adv Med Oncol       Date:  2019-09-24       Impact factor: 8.168

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.